154 related articles for article (PubMed ID: 31281478)
1. Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of AKT.
Huang G; Hu H; Zhang Y; Zhu Y; Liu J; Tan B; Chen T
J Cancer; 2019; 10(13):3012-3020. PubMed ID: 31281478
[TBL] [Abstract][Full Text] [Related]
2. Anti-cancer and Sensibilisation Effect of Triptolide on Human Epithelial Ovarian Cancer.
Hu H; Luo L; Liu F; Zou D; Zhu S; Tan B; Chen T
J Cancer; 2016; 7(14):2093-2099. PubMed ID: 27877225
[No Abstract] [Full Text] [Related]
3. Inhibition effect of triptolide on human epithelial ovarian cancer via adjusting cellular immunity and angiogenesis.
Hu H; Huang G; Wang H; Li X; Wang X; Feng Y; Tan B; Chen T
Oncol Rep; 2018 Mar; 39(3):1191-1196. PubMed ID: 29286149
[TBL] [Abstract][Full Text] [Related]
4. Triptolide inhibits JAK2/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin‑resistant SKOV3/DDP ovarian cancer cells.
Zhong Y; Le F; Cheng J; Luo C; Zhang X; Wu X; Xu F; Zuo Q; Tan B
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760192
[TBL] [Abstract][Full Text] [Related]
5. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].
Chen J; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987
[TBL] [Abstract][Full Text] [Related]
6. TPL Inhibits the Invasion and Migration of Drug-Resistant Ovarian Cancer by Targeting the PI3K/AKT/NF-κB-Signaling Pathway to Inhibit the Polarization of M2 TAMs.
Le F; Yang L; Han Y; Zhong Y; Zhan F; Feng Y; Hu H; Chen T; Tan B
Front Oncol; 2021; 11():704001. PubMed ID: 34381726
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment.
Qin L; Qiu H; Zhang M; Zhang F; Yang H; Yang L; Jia L; Qin K; Jia L; Dou X; Cheng L; Sang M; Zhang C; Shan B; Zhang Z
Biomed Pharmacother; 2016 Apr; 79():166-75. PubMed ID: 27044825
[TBL] [Abstract][Full Text] [Related]
8. Circadian Clock Protein PERIOD2 Suppresses the PI3K/Akt Pathway and Promotes Cisplatin Sensitivity in Ovarian Cancer.
Wang Z; Li F; Wei M; Zhang S; Wang T
Cancer Manag Res; 2020; 12():11897-11908. PubMed ID: 33244267
[TBL] [Abstract][Full Text] [Related]
9. Guizhi Fuling Wan, a Traditional Chinese Herbal Formula, Sensitizes Cisplatin-Resistant Human Ovarian Cancer Cells through Inactivation of the PI3K/AKT/mTOR Pathway.
Han L; Guo X; Bian H; Yang L; Chen Z; Zang W; Yang J
Evid Based Complement Alternat Med; 2016; 2016():4651949. PubMed ID: 27293459
[TBL] [Abstract][Full Text] [Related]
10. Lanthanum Chloride Sensitizes Cisplatin Resistance of Ovarian Cancer Cells
Fang S; Zhang P; Chen X; Liu F; Wang F
Front Med (Lausanne); 2021; 8():776876. PubMed ID: 34977076
[TBL] [Abstract][Full Text] [Related]
11. TRIAP1 Inhibition Activates the Cytochrome c/Apaf-1/Caspase-9 Signaling Pathway to Enhance Human Ovarian Cancer Sensitivity to Cisplatin.
Zhang TM
Chemotherapy; 2019; 64(3):119-128. PubMed ID: 31661694
[TBL] [Abstract][Full Text] [Related]
12. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
Shen W; Liang B; Yin J; Li X; Cheng J
Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
[TBL] [Abstract][Full Text] [Related]
13. Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy.
Zhang HY; Zhang PN; Sun H
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):81-6. PubMed ID: 19540648
[TBL] [Abstract][Full Text] [Related]
14. Triptolide avoids cisplatin resistance and induces apoptosis via the reactive oxygen species/nuclear factor-κB pathway in SKOV3
Zhong YY; Chen HP; Tan BZ; Yu HH; Huang XS
Oncol Lett; 2013 Oct; 6(4):1084-1092. PubMed ID: 24137468
[TBL] [Abstract][Full Text] [Related]
15. ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells.
Xu Y; Gao W; Zhang Y; Wu S; Liu Y; Deng X; Xie L; Yang J; Yu H; Su J; Sun L
Int J Oncol; 2018 Sep; 53(3):1055-1068. PubMed ID: 30015875
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of PI3K/Akt/mTOR signaling pathway enhances the sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin in vitro.
Cai Y; Tan X; Liu J; Shen Y; Wu D; Ren M; Huang P; Yu D
Chin J Cancer Res; 2014 Oct; 26(5):564-72. PubMed ID: 25400422
[TBL] [Abstract][Full Text] [Related]
17. GTW inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer via ILK/AKT/GSK3β/Slug Signalling Pathway.
Feng Y; Le F; Tian P; Zhong Y; Zhan F; Huang G; Hu H; Chen T; Tan B
J Cancer; 2021; 12(5):1386-1397. PubMed ID: 33531984
[No Abstract] [Full Text] [Related]
18. Effect of tamoxifen, methoxyprogesterone acetate and combined treatment on cellular proliferation and apoptosis in SKOV3/DDP cells via the regulation of vascular endothelial growth factor.
Wen L; Hong D; Yanyin W; Mingyue Z; Baohua L
Arch Gynecol Obstet; 2013 May; 287(5):997-1004. PubMed ID: 23212665
[TBL] [Abstract][Full Text] [Related]
19. LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions.
Ju X; Yu H; Liang D; Jiang T; Liu Y; Chen L; Dong Q; Liu X
Biomed Pharmacother; 2018 Jun; 102():549-554. PubMed ID: 29597088
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of Topo II alpha gene expression and reversing of drug resistance in multi-drug resistant epithelial ovarian cancer cells induced by RNA interference in vitro].
He J; Li L; Tang BJ; Zhang W; Li DR; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):686-90. PubMed ID: 20079182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
